CGS-15943 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets adenosine A1 receptor, adenosine A2A receptor, adenosine A2B receptor, adenosine A3 receptor, p110δ, and p110γ.
CGS-15943 can be used for research on the role of adenosine receptors in various physiological and pathological processes in the central nervous system.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.